Pedigree

Sector: Retail (Pet Shop & Veterinary Clinic Business Plan &)  |  HQ: India  |  Founded: Not separately disclosed  |  Employees: Not separately disclosed

Listed as: Privately held  | 

Company overview

Pedigree operates in the retail segment of the Indian market, with a presence noted in the pet shop & veterinary clinic business plan & category. The company is among the recognised participants in this segment alongside other Indian and multinational players. Operations follow the standard Companies Act 2013 disclosure framework where Pedigree is incorporated as a private or public limited company under Indian law, with statutory audit, GST registration under the CGST Act 2017, and applicable sectoral compliance under FSSAI, BIS, MoEF, or sectoral regulators as relevant to the activity. The competitive set in pet shop & veterinary clinic business plan & includes pan-India brands, regional players, and multinational subsidiaries operating in India through wholly-owned or joint-venture structures.

Recent developments

October 2025 - April 2026

Pedigree India has intensified its marketing efforts through high-profile celebrity endorsements and technology-driven campaigns. The brand partnered with Indian cricketers KL Rahul and Suryakumar Yadav in October 2025 to raise awareness around science-backed pet nutrition, positioning its products as a scientifically formulated choice for dogs [4][6]. This was followed by a partnership with cricketer Jemimah Rodrigues in April 2026, launching a dedicated gravy and wet dog food campaign emphasising complete everyday nutrition [2][5][7][9][10]. The messaging consistently highlights the nutritional science behind Pedigree products rather than generic pet feeding appeals. Separately, Pedigree India deployed AI technology to compose a themed 'Pawsome Playlist', representing a modern digital marketing approach [1]. Historical market share data published by Statista in November 2025 covering the 2013–2017 period provides baseline context for the brand's competitive position in India [3].

Sources (9)

1. PEDIGREE India Uses AI to Compose a ‘Pawsome Playlist’ - IMPACT Magazine · IMPACT Magazine · Mon, 27 Oct 2025
2. Pedigree taps Jemimah Rodrigues for gravy campaign - Campaign India · Campaign India · Sat, 18 Apr 2026
3. Market share of Pedigree in India between 2013 and 2017 - Statista · Statista · Tue, 25 Nov 2025
4. KL Rahul and SKY Join Hands with The PEDIGREE® Brand in India to Raise Awareness on Science Backed Pet Food - TheWire.in · TheWire.in · Wed, 15 Oct 2025
5. PEDIGREE campaign with Jemimah Rodrigues promotes wet dog food as complete everyday nutrition choice - MediaNews4U · MediaNews4U · Fri, 17 Apr 2026
6. KL Rahul and Suryakumar Yadav bats for science backed nutritious meals for their furry companions with Pedig.. - ET BrandEquity · ET BrandEquity · Wed, 08 Oct 2025
7. Jemimah Rodrigues Teams Up with Pedigree to Champion Nutrient-Rich Gravy for Pets - Telugu Times · Telugu Times · Fri, 24 Apr 2026
8. Mars Pet Nutrition Launches PEDIGREE Gravy Campaign with Jemimah Rodrigues - Indian Retailer · Indian Retailer · Sat, 18 Apr 2026
9. PEDIGREE brings in Jemimah Rodrigues for wet food campaign - afaqs! · afaqs! · Fri, 17 Apr 2026

Financial performance and recent trajectory

Disclosed revenue (FY25): Not separately disclosed in segment-wise FY 2024-25 reporting.

Competitive position

Pedigree occupies a position in the pet shop & veterinary clinic business plan & category alongside other listed and unlisted Indian players. Competitive intensity in the segment is shaped by raw material cost cycles, distribution depth, branded versus unbranded share, and the regulatory framework governing manufacturing, FSSAI labelling (for food), BIS standards (for engineering goods), or sectoral norms. The principal competitive moats in this category are typically scale, distribution reach, brand trust, and integrated procurement. KAMRIT's project report on pet shop & veterinary clinic business plan & benchmarks new entrant economics against the listed peer cost structure including capex per tonne (or per unit of output), working capital intensity, gross margin band, and the EBITDA delta between organised and unorganised participants.

Key risks

Input cost volatility in the pet shop & veterinary clinic business plan & value chain Competitive intensity from larger Indian groups and multinational subsidiaries Regulatory tightening under FSSAI, BIS, environmental norms, or labour codes

Outlook

Pedigree is a participant in the Indian pet shop & veterinary clinic business plan & category, which forms part of the broader Retail space. The Indian pet shop & veterinary clinic business plan & market continues to evolve with rising organised share, premiumisation, distribution expansion, and a regulatory architecture covering the Companies Act 2013, the Income Tax Act 1961, the CGST Act 2017, the Legal Metrology Act 2009, and sectoral statutes including the Food Safety and Standards Act 2006 (for food and beverage subsegments), the Drugs and Cosmetics Act 1940 (for pharmaceutical or healthcare adjacencies), the Environment Protection Act 1986 (for emissions and effluents), and labour codes consolidated under the four 2020 labour codes. In KAMRIT's project report framework for this category, the competitive set typically includes pan-India branded leaders, multinational subsidiaries, mid-sized regional players, and a long tail of MSME participants. The structural attractiveness of the category for new entrants is a function of (a) market growth rate, (b) the share that remains with unorganised or fragmented operators, (c) the cost of regulatory compliance, and (d) the capex intensity of plant and machinery. The KAMRIT bankable DPR for this category structures a new entrant's economics against this competitive landscape. For Pedigree specifically, public-domain disclosures provide a baseline view of operations, but segment-wise revenue, EBITDA, capacity utilisation, and forward capex plans are not separately broken out in many cases. Where the company is part of a listed group, the SEBI LODR and the Companies Act 2013 governance framework apply, with statutory audit conducted under SA 700 and CARO 2020 reporting. Where the company is unlisted, the Companies Act 2013 framework continues to govern with reduced public disclosure. The risk and opportunity outlook for Pedigree mirrors the broader pet shop & veterinary clinic business plan & category dynamics. Demand-side drivers include rising household consumption, urbanisation, organised retail expansion, and policy support including PLI schemes (where applicable to the segment). Supply-side risks include input cost volatility, regulatory tightening, environmental compliance escalation, and competitive intensity from larger groups or imports. Management quality, balance sheet strength, distribution depth, and the capex execution track record are the differentiators within the peer set. KAMRIT's research desk maintains a baseline reference for Pedigree as a peer benchmark within the pet shop & veterinary clinic business plan & category. For investors, lenders, or new entrant promoters seeking a fuller assessment of Pedigree, KAMRIT's deep-dive company profile engagement covers financial trajectory, capacity and capex, distribution and customer concentration, regulatory exposure, and the competitive position with named peers.

KAMRIT point of view

Building or competing with Pedigree?

KAMRIT advises promoters, family offices, and global enterprises evaluating greenfield entry into the retail (pet shop & veterinary clinic business plan &) sector. Our Bankable DPR with Cost Model and ROI benchmarks your project economics against the listed-company cost structure of Pedigree and peers. The Execution Partnership tier covers everything from incorporation through commissioning. A 20-minute scoping call with our partners is free.

View all 1 related project report → Book a scoping call

Related KAMRIT project reports

These reports use Pedigree in benchmarking and competitive analysis sections.

Disclaimer: This profile is compiled by KAMRIT Financial Services LLP for educational and benchmarking purposes only. It is not investment advice, a recommendation to buy or sell securities, or a solicitation. Stock data is provided by Yahoo Finance and may be delayed by up to 20 minutes. Company financial commentary draws on publicly available filings, exchange disclosures, and KAMRIT industry research. Readers should consult a SEBI-registered investment adviser before making investment decisions. KAMRIT is a financial services and compliance firm, not a SEBI-registered investment adviser.